These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 23564400

  • 1. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, Serisier DJ.
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [Abstract] [Full Text] [Related]

  • 2. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB, Bruce KD, Martin ML, Burr LD, Serisier DJ.
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [Abstract] [Full Text] [Related]

  • 3. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB, Zain NM, Bruce KD, Burr LD, Chen AC, Rivett DW, McGuckin MA, Serisier DJ.
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
    Taylor SL, Rogers GB, Chen AC, Burr LD, McGuckin MA, Serisier DJ.
    Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.
    Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS.
    Am J Respir Crit Care Med; 2008 May 01; 177(9):995-1001. PubMed ID: 18263800
    [Abstract] [Full Text] [Related]

  • 9. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
    Stressmann FA, Rogers GB, van der Gast CJ, Marsh P, Vermeer LS, Carroll MP, Hoffman L, Daniels TW, Patel N, Forbes B, Bruce KD.
    Thorax; 2012 Oct 01; 67(10):867-73. PubMed ID: 22707521
    [Abstract] [Full Text] [Related]

  • 10. PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.
    Burr LD, Rogers GB, Chen AC, Taylor SL, Bowler SD, Keating RL, Martin ML, Hasnain SZ, McGuckin MA.
    PLoS One; 2018 Oct 01; 13(8):e0202296. PubMed ID: 30114278
    [Abstract] [Full Text] [Related]

  • 11. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK, Chang J, Kim HJ, Jeong SH.
    PLoS One; 2017 Oct 01; 12(8):e0183553. PubMed ID: 28829833
    [Abstract] [Full Text] [Related]

  • 12. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways.
    Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J, Sperling AI, Solway J, Naureckas ET, Gilbert JA, White SR.
    J Allergy Clin Immunol; 2016 May 01; 137(5):1398-1405.e3. PubMed ID: 26627545
    [Abstract] [Full Text] [Related]

  • 13. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
    Burr LD, Rogers GB, Chen AC, Hamilton BR, Pool GF, Taylor SL, Venter D, Bowler SD, Biga S, McGuckin MA.
    Ann Am Thorac Soc; 2016 Oct 01; 13(10):1697-1703. PubMed ID: 27464029
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The microbial community of the cystic fibrosis airway is disrupted in early life.
    Renwick J, McNally P, John B, DeSantis T, Linnane B, Murphy P, SHIELD CF.
    PLoS One; 2014 Oct 01; 9(12):e109798. PubMed ID: 25526264
    [Abstract] [Full Text] [Related]

  • 17. Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis.
    O'Neill K, Einarsson GG, Rowan S, McIlreavey L, Lee AJ, Lawson J, Lynch T, Horsley A, Bradley JM, Elborn JS, Tunney MM.
    Respirology; 2020 Jan 01; 25(1):64-70. PubMed ID: 31364220
    [Abstract] [Full Text] [Related]

  • 18. Bacterial colonisation of lower airways in health and chronic lung disease.
    Weinreich UM, Korsgaard J.
    Clin Respir J; 2008 Apr 01; 2(2):116-22. PubMed ID: 20298316
    [Abstract] [Full Text] [Related]

  • 19. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
    Kolak M, Karpati F, Monstein HJ, Jonasson J.
    Int J Med Microbiol; 2003 Aug 01; 293(4):309-17. PubMed ID: 14503795
    [Abstract] [Full Text] [Related]

  • 20. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B, Davies JC, Wilson R, Shoemark A, Williams HD.
    Eur Respir J; 2008 Sep 01; 32(3):740-7. PubMed ID: 18480102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.